Capsulomics, Inc.

Amendment
CIK: 0001800623·Biotechnology·MARYLAND·Filed: Mar 19, 2025
Total Offering

$3,000,000

Amount Sold

$2,392,270

Investors

10

First Sale

Dec 17, 2019

Offering Details

Type
Other: Simple Agreement for Future Equity [SAFE]
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Daniel Lunz
Related Person
Stephen Meltzer
Related Person
John Neiderhuber
Related Person
William Stevens
Related Person

Company

Capsulomics, Inc.

1450 S ROLLING ROAD

HALETHORPE, MD, 21227

8778444487

SEC Filing

0001800623-25-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Capsulomics, Inc. Form D Filing — $3,000,000 | FilingFlow